Acridine carboxamide

Acridine derivative used in cancer treatment

Chemical Compound
Identifiers
CAS Number
PubChem CID
ChemSpider ID
UNII
ChEBI
ChEMBL
Properties
Chemical Formula
Molar Mass
Appearance
Density
Melting Point
Boiling Point
Hazards
GHS Pictograms	[[File:|50px]]
GHS Signal Word
GHS Hazard Statements
NFPA 704	[[File:|50px]]
References

Acridine carboxamide is a chemical compound that belongs to the class of acridine derivatives. It has been studied for its potential use in cancer treatment due to its ability to intercalate into DNA and inhibit topoisomerase enzymes.

Chemical Structure

Acridine carboxamide is characterized by its acridine core, which is a planar, tricyclic aromatic system. The carboxamide group is attached to the acridine ring, which is crucial for its biological activity. The structure allows it to intercalate between DNA base pairs, disrupting the normal function of the DNA molecule.

Mechanism of Action

Acridine carboxamide exerts its effects primarily through DNA intercalation. By inserting itself between the base pairs of the DNA double helix, it disrupts the normal processes of DNA replication and transcription. Additionally, acridine carboxamide inhibits the activity of topoisomerase enzymes, which are essential for DNA unwinding and replication. This dual action makes it a potent antitumor agent.

Clinical Applications

Acridine carboxamide has been investigated in clinical trials for its efficacy in treating various types of cancer, including leukemia, lymphoma, and solid tumors. Its ability to target rapidly dividing cells makes it a promising candidate for chemotherapy regimens. However, its clinical use is limited by potential side effects and the development of drug resistance.

Side Effects

The use of acridine carboxamide in cancer therapy can lead to several side effects, which are common to many chemotherapeutic agents. These include myelosuppression, nausea, vomiting, and alopecia. Careful monitoring and supportive care are essential to manage these adverse effects during treatment.

Research and Development

Ongoing research is focused on improving the efficacy and safety profile of acridine carboxamide. Modifications to its chemical structure aim to enhance its selectivity for cancer cells and reduce toxicity. Additionally, combination therapies with other anticancer agents are being explored to overcome resistance and improve patient outcomes.

Related pages

• Acridine
• DNA intercalation
• Topoisomerase
• Chemotherapy